Wells Fargo analyst Gabrial Hajde maintains $AptarGroup (ATR.US)$ with a buy rating, and adjusts the target price from $168 to $185.
According to TipRanks data, the analyst has a success rate of 57.4% and a total average return of 4.3% over the past year.
Furthermore, according to the comprehensive report, the opinions of $AptarGroup (ATR.US)$'s main analysts recently are as follows:
Ahead of quarterly results in the packaging and containers sector, there is an anticipation that Q3 demand has seen a sequential improvement. However, a dramatic uptick is not expected due to prevailing cautious sentiment among consumers and industrial sectors. It is suggested the most challenging period has passed, but expectations are tempered with a projection of flat volume trends rather than a low single-digit increase for the year. A recovery is thought to be more likely during the first half of 2025.
AptarGroup's Pharma segment is anticipated to drive an 8.5% annual EBITDA growth through 2026, bolstered by a robust pipeline of new products including delivery systems for GLP-1 drugs, over-the-counter Narcan, and Neffy. This growth trajectory is expected to align the company's valuation more closely with its peers in the healthcare packaging sector.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
富國集團分析師Gabrial Hajde維持$AptarGroup (ATR.US)$買入評級，並將目標價從168美元上調至185美元。
根據TipRanks數據顯示，該分析師近一年總勝率為57.4%，總平均回報率為4.3%。
此外，綜合報道，$AptarGroup (ATR.US)$近期主要分析師觀點如下：
在包裝和容器行業公佈季度業績之前，預計第三季度的需求將連續改善。但是，由於消費者和工業部門普遍持謹慎情緒，預計不會出現大幅上漲。據稱，最具挑戰性的時期已經過去，但由於預測全年銷量呈平穩趨勢，而不是較低的個位數增長，預期受到抑制。據認爲，2025年上半年復甦的可能性更大。
預計到2026年，AptarGroup的製藥板塊將推動8.5％的年度息稅折舊攤銷前利潤增長，這得益於包括 GLP-1 藥物遞送系統、非處方Narcan和Neffy在內的強大新產品管線。預計這一增長軌跡將使該公司的估值與醫療包裝領域的同行更加接近。
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
